Details
Stereochemistry | ACHIRAL |
Molecular Formula | C18H22N7O10.Na |
Molecular Weight | 519.3979 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].CC1=NC=C(N1CCOC(=O)CN(CC([O-])=O)CC(=O)OCCN2C(C)=NC=C2[N+]([O-])=O)[N+]([O-])=O
InChI
InChIKey=FWYUJENICVGSJH-UHFFFAOYSA-M
InChI=1S/C18H23N7O10.Na/c1-12-19-7-14(24(30)31)22(12)3-5-34-17(28)10-21(9-16(26)27)11-18(29)35-6-4-23-13(2)20-8-15(23)25(32)33;/h7-8H,3-6,9-11H2,1-2H3,(H,26,27);/q;+1/p-1
Sodium glycididazole (CMNA), a nitroimidazole compound that has a radiation-enhancing effect. This drug was studied in the treatment of patients with various tumors, such as non-small-cell lung cancer, esophageal carcinoma. CMNA combined with chemoradiotherapy participated in phase II clinical trials in patients with locally recurrent squamous cell esophageal carcinoma. It was shown, that CMNA improved curative effects without increasing adverse reactions, and significantly increase survival rates of the patients. The precise mechanism of action CMNA is not clear but is known that it acts through downregulation of ATM signaling pathway.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: WP2516 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26586399 |
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT02721576
Sodium Glycididazole (CMNa) 800mg/m2.Three times a week (once every other one day),before radiation therapy, total 5-6 weeks.
Route of Administration:
Intravenous
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C798
Created by
admin on Sat Dec 16 09:21:55 GMT 2023 , Edited by admin on Sat Dec 16 09:21:55 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
300000037464
Created by
admin on Sat Dec 16 09:21:55 GMT 2023 , Edited by admin on Sat Dec 16 09:21:55 GMT 2023
|
PRIMARY | |||
|
298688-44-5
Created by
admin on Sat Dec 16 09:21:55 GMT 2023 , Edited by admin on Sat Dec 16 09:21:55 GMT 2023
|
SUPERSEDED | |||
|
9914614
Created by
admin on Sat Dec 16 09:21:55 GMT 2023 , Edited by admin on Sat Dec 16 09:21:55 GMT 2023
|
PRIMARY | |||
|
173357-17-0
Created by
admin on Sat Dec 16 09:21:55 GMT 2023 , Edited by admin on Sat Dec 16 09:21:55 GMT 2023
|
PRIMARY | |||
|
DTXSID60432742
Created by
admin on Sat Dec 16 09:21:55 GMT 2023 , Edited by admin on Sat Dec 16 09:21:55 GMT 2023
|
PRIMARY | |||
|
5YV419FIJS
Created by
admin on Sat Dec 16 09:21:55 GMT 2023 , Edited by admin on Sat Dec 16 09:21:55 GMT 2023
|
PRIMARY | |||
|
C77889
Created by
admin on Sat Dec 16 09:21:55 GMT 2023 , Edited by admin on Sat Dec 16 09:21:55 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD